Used as a key active pharmaceutical ingredient in the development of SGLT2 inhibitors for the treatment of type 2 diabetes. It helps lower blood glucose levels by blocking the reabsorption of glucose in the kidneys, promoting its excretion through urine. Due to its specific stereochemistry, it exhibits high selectivity and potency against SGLT2, leading to improved glycemic control with reduced risk of hypoglycemia. Also investigated for potential benefits in cardiovascular and renal protection in diabetic patients.